Tennessee SB 2099: Controlled Substances - As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.

Status: Effective date(s) 04/12/2018 (as of 2018-04-17)

State: Tennessee · Session: 110 · Bill: SB 2099

Subjects: Controlled Substances

Sponsors: Dickerson, Terry

View Tennessee SB 2099 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.